Skip to main content Accessibility help
×
Hostname: page-component-5d59c44645-kw98b Total loading time: 0 Render date: 2024-02-22T17:21:28.868Z Has data issue: false hasContentIssue false

Chapter 12 - Amyotrophic lateral sclerosis

Published online by Cambridge University Press:  05 July 2012

James E. Barrett
Affiliation:
Drexel University, Philadelphia
Joseph T. Coyle
Affiliation:
Harvard University School of Medicine, Massachusetts
Michael Williams
Affiliation:
Drexel University, Philadelphia
Get access

Summary

Amyotrophic lateral sclerosis (ALS) is the most common form of adult motor neuron disease. A brief overview of some of the more important genes identified in familial ALS is provided. To date, riluzole is the only drug that has demonstrated efficacy in patients with ALS. One of the most challenging aspects in translating candidate therapeutic agents for ALS to clinical use is the appropriate clinical trial design. ALS-relevant compounds has recently increased, and the potential for interfering RNA (RNAi) and antisense technologies to target a specific but well-characterized (mutant superoxide dismutase 1) protein responsible for many cases of familial ALS may offer proof of the principle that ALS can be effectively treated if the upstream causative etiologies are identified. Finally, recent advances in stem cell research, including the development of induced pluripotent stem cells, offer the potential for autologous cell transplantation as well as drug discovery.
Type
Chapter
Information
Translational Neuroscience
Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders
, pp. 214 - 227
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×